ASH Clinical News September 2017 New | Página 74

Heard in the Blogosphere Mark Lewis, MD John Sherbeck, MD @marklewismd @TeamCaptainJohn I’m an oncologist having surgery to remove pancreatic cancer. No one is immune from disease; bad luck should bankrupt no one. #skinnyrepeal Mark Reid, MD @medicalaxioms If you don’t intend to look at the result, don’t order the test. As your #bloodbank fellow, hope every1 at @umichmedicine joins me at the @RedCrossBloodDT drive today! #blooducation Colleen Plein, MD @DrPleinENT Healthcare system in a nutshell: got email from admin today re fighting burnout. Their solution? Take an online training module. Neha Bhatnagar, MD @nbhatnagar_md Lesson for budding docs: “Spend 3 more minutes in the room, ask 2 more questions, and do 1 less test.” Dr. Zane at @DenverEMed Frank Ingram, MD @Chucktowndoc There’s gonna be at least 1 great case in there! (What I say so I don’t cry when the afternoon stack arrives.) #Pathology #optimism #BigStack Robert Paul Musgrave, PhD @profmusgrave Write your abstracts like they’re the only paragraph anyone will read. Also: your abstract is the only paragraph anyone will read. Gavin Preston, MD @GavinPrestonMD I see more and more urgent care centers. It is the opposite of the long-lasting, stable doctor-patient relationship where trust grows. #meded David Tom Cooke, MD @DavidCookeMD Best “negative” eval I received: “He has too high expectations of the residents.” Just the same expectations my faculty had of me! #meded Christine Garcia, MPH, MD @christinemphmd My dog seems to be interested in learning some #HemePath! #Pathology The Upside of Bad Genes “The promise of [CRISPR/Cas9] is that it will transform medicine by vanquishing previously incurable diseases, [but] scientists really don’t understand enough about the upside of genes we consider ‘bad’ to begin editing them willy-nilly. … New pathogens for which we don’t have cures continue to emerge, [and] those ‘bad’ gene variants might still come in handy. More broadly, genetically diverse populations tend to be more resilient, precisely because they have more genetic resources to draw on when unforeseen challenges arise. … Certainly, some genes will turn out to be only detrimental and provide no advantage. But there are bound to be other cases … in which genes deemed harmful can aid survival or at least cause less damage in other surroundings. … Given how much the world has changed in just the past 150 years, and how much it’s likely to change again in the next 150, the question is, ‘What environment will we optimize our genes for?’” —Moises Velasquez-Manoff, on the downsides of potentially over-correcting the human genome, in The New York Times What’s Missing From the Health-Care Debate? Patients’ Voices “Sadly, the most important voices – those of patients, the people most directly affected by any new law – have been largely unheard [in the health-care debate]. Patients have the most extensive experience in dealing directly with our complicated health-care system and also understand the stark reality of what it means to lose affordable access to health care. … Without elevating the voice of patients and taking their thoughts to heart in forming this law, the country st